Where it comes from
- Made in
- Adrenal medulla, heart, vessels and brain, cut from the same precursor as adrenomedullin
- Sent out by
- With adrenomedullin
- Acts on
- Sympathetic nerve endings
- Adrenal chromaffin cells
- Blood vessels
What it does
In medicine
- No test and no medicine. MR-proADM, the assay hospitals use, measures a different stretch of the same precursor and says nothing about PAMP
- Plasma PAMP is reported to be higher in essential hypertension and in phaeochromocytoma, from a handful of research assays and small series
- Its receptor is not settled. MRGPRX2 responds to it in cells, and that is the receptor behind the flushing some injected medicines cause, so anything built on PAMP would have that to answer for 2
Beyond the body’s own use
- It was found in 1994 by asking what else the adrenomedullin precursor yields, and its blood-pressure-lowering effect was shown in rats in the same paper 1
- The antimicrobial work is all in the dish: cell selectivity and membrane mechanism have been described, with no animal infection model behind them 3
- Nothing is in trials. What would settle its place is simple and still missing: an animal that makes adrenomedullin but not PAMP, since the two always come from one precursor 1
Sources
- Kitamura et al., Identification and hypotensive activity of proadrenomedullin N-terminal 20 peptide, FEBS Letters 1994
- Kamohara et al., Identification of MrgX2 as a receptor for proadrenomedullin N-terminal peptides, Biochemical and Biophysical Research Communications 2005
- Ajish et al., PAMP and its C-terminal fragment: cell selectivity and antimicrobial mechanism, Biochemical and Biophysical Research Communications 2020
This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.